Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.

Plain-English Summary

This bill would remove testosterone prescriptions from Rhode Island's prescription drug monitoring database (PDMP) — a statewide system that tracks when controlled substances are prescribed and dispensed. Under current law, testosterone is included in this tracking system. If this bill passes, pharmacies and healthcare providers would no longer be required to report testosterone prescriptions to the database, and any existing testosterone prescription records already stored there would be deleted.

The prescription drug monitoring database is primarily used by healthcare providers, pharmacists, and law enforcement to identify potential misuse or overprescribing of controlled substances. This bill would affect anyone in Rhode Island who currently takes or has previously been prescribed testosterone — including people using it for hormone therapy, medical conditions like hypogonadism, or other health needs. Their prescription history related to testosterone would no longer be visible in the state tracking system.

Supporters of measures like this often argue that removing certain prescriptions from monitoring databases protects patient privacy, particularly for transgender individuals who use testosterone as part of gender-affirming care. Those with concerns about such changes might raise questions about the ability to monitor potential misuse of the substance. The bill is currently in the early stages of the legislative process, having been referred to the Senate Health and Human Services Committee for review.